How Bio-based Caprolactone is Produced
Key Pathways:
- Bio-cyclohexanone Route
- Bio-based feedstocks (e.g., glucose, muconic acid, or lignin aromatics) are converted to cyclohexanone via hydrogenation and ring formation, which is then oxidized to caprolactone using Baeyer–Villiger oxidation.
- Adipic Acid Intermediate Route
- Fermentation-derived adipic acid is chemically reduced to 1,6-hexanediol, which is cyclized via dehydrogenation to form caprolactone.
- Direct Fermentative Pathway (Emerging)
- Engineered microbes are being explored to convert sugars directly into caprolactone or precursors — at early R&D stage.
Feedstocks: Glucose, lignin monomers, muconic acid, bio-adipic acid.
Case Study: DSM & Novomer – Bio-based Caprolactone Platform
Highlights:
- Developed bio-adipic acid and intermediates from CO₂ and ethanol feedstocks, enabling downstream synthesis of PCL and copolymers.
- Aimed at specialty polyurethanes, adhesives, and medical-grade resins.
Timeline & Outcome:
- 2017: DSM acquires rights to Novomer’s CO₂-based polymer IP.
- 2020: Proof of concept for bio-polycaprolactone derived from bio-based intermediates.
- 2022–2024: Scale-up studies and early commercialization in polyurethane segments.
Global Startups Working on Bio-caprolactone
- Cyclonel (France) – Converts biomass-derived sugars to lactones and ε-caprolactone for use in coatings and biodegradable plastics.
- Melio Peptides (Germany) – Targets biomedical-grade polycaprolactone using renewable C6 intermediates.
- Novomer (USA) – Focuses on CO₂-based C1 intermediates to synthesize C6 and C7 monomers including caprolactone.
- DMC Biotechnologies (USA) – Exploring fermentation routes to caprolactone precursors from renewable carbon.
India’s Position
- India’s surplus sugar and lignin streams from agro-industrial sectors provide feedstock potential.
- No startup is yet commercializing caprolactone or PCL, but the biomedical materials market in India is expanding rapidly.
Commercialization Outlook
Market & Demand
- Global caprolactone market: ~$600 million (2024), projected to exceed ~$950 million by 2030.
- Major applications:
- Biodegradable PCL polymers
- Hot-melt adhesives and specialty coatings
Key Drivers
- Surge in demand for biodegradable packaging and medical polymers.
- Brand shift to non-toxic, non-PVC-based resins.
- Technological compatibility with existing PCL and polyurethane systems.
- Advances in CO₂ and lignin utilization for circular carbon.
Challenges to Address
- Oxidation Chemistry: Baeyer–Villiger oxidation requires hazardous oxidants and high selectivity.
- Cost: Bio-based cyclohexanone or adipic acid adds ~40–60% cost premium over fossil.
- Scale: Global bio-based caprolactone production is <5% of total demand.
- Regulatory Pathways: Especially for medical and FDA-grade PCL, rigorous validation needed.
Progress Indicators
- 2017–2019: Proof of concept by Novomer and DSM on CO₂-to-caprolactone platform.
- 2020–2022: Pilot trials of bio-based PCL for medical coatings and adhesives.
- 2023–2024: Expansion of renewable caprolactone product lines in Europe.
- India: Academic work on lignin/cyclohexanone valorization; no startup-level activity yet.
Bio-based caprolactone via sugar-to-cyclohexanone oxidation is at TRL 6–7 (pilot scale). Routes via bio-adipic acid and 1,6-hexanediol are at TRL 7–8. Fully fermentative pathways are at TRL 3–4
Conclusion
Bio-based caprolactone is emerging as a critical intermediate for next-gen biodegradable polyesters and green polyurethanes, with applications spanning from medical materials to adhesives. Companies like Novomer and Cyclonel have demonstrated renewable routes that are compatible with industrial polymer synthesis. India, with its abundant biomass and biomedical market, holds untapped potential for future caprolactone production. As bio-feedstock conversion improves and demand for low-toxicity polymers rises, bio-caprolactone is set to strengthen the bridge between sustainability and high-performance materials.
Wish to have bio-innovations industry or market research support from specialists for climate & environment? Talk to BioBiz team – Call Muthu at +91-9952910083 or send a note to ask@biobiz.in
Expert Consulting Assistance for Indian Bioenergy & Biomaterials
Talk to BioBiz
Call Muthu – 9952910083
Email – ask@biobiz.in
